Does ADALIMUMAB Cause Injection site swelling? 4,428 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,428 reports of Injection site swelling have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.9% of all adverse event reports for ADALIMUMAB.
4,428
Reports of Injection site swelling with ADALIMUMAB
0.9%
of all ADALIMUMAB reports
0
Deaths
288
Hospitalizations
How Dangerous Is Injection site swelling From ADALIMUMAB?
Of the 4,428 reports, 288 (6.5%) required hospitalization, and 8 (0.2%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 4,428 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
CERTOLIZUMAB PEGOL (782)
Which ADALIMUMAB Alternatives Have Lower Injection site swelling Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB